Altered corticosteroid biosynthesis in essential hypertension: A digenic phenomenon

Molecular and Cellular Endocrinology

Volumn 300, Issue 1-2, 2009, Pages 185-191

  Davies, Eleanor ^a   MacKenzie, Scott M ^a   Freel, E Marie ^a   Alvarez Madrazo, Samantha ^a   Fraser, Robert ^a   Connell, John M C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aldosterone; Essential hypertension; Genetics

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; STEROID 11BETA MONOOXYGENASE;

ALDOSTERONE BLOOD LEVEL; BIRTH WEIGHT; BLOOD PRESSURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE; GENE LOCUS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; STEROIDOGENESIS;

ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOOD PRESSURE; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; STEROID 11-BETA-HYDROXYLASE;

EID: 59649090400     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.09.014     Document Type: Review

References (75)

1. Barr M., MacKenzie S.M., Friel E.C., Holloway C.D., Wilkinson D.M., Brain N.J., Ingram M.C., Fraser R., Brown M., Samani N.J., Caulfield M., Munroe P.B., Farrall M., Webster J., Clayton D., Dominiczak A.F., Connell J.M., and Davies E. Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 49 1 (2007) 113-119
2. Bassett M.H., Zhang Y., Clyne C., White P.C., and Rainey W.E. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J. Mol. Endocrinol. 28 2 (2002) 125-135
3. Bhalla V., Soundararajan R., Pao A.C., Li H., and Pearce D. Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. Am. J. Physiol. Renal Physiol. 291 4 (2006) F714-F721
4. Biglieri E.G., Hane S., Slaton Jr. P.E., and Forsham P.H. In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism. J. Clin. Invest. 42 (1963) 516-524
5. Brand E., Chatelain N., Mulatero P., Fery I., Curnow K., Jeunemaitre X., Corvol P., Pascoe L., and Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32 2 (1998) 198-204
6. Calhoun D.A., Nishizaka M.K., Zaman M.A., Thakkar R.B., and Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40 6 (2002) 892-896
7. Cherradi N., Brandenburger Y., and Capponi A.M. Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and StAR protein. Eur. J. Endocrinol. 139 (1998) 249-256
8. Chua S.C., Szabo P., Vitek A., Grzeschik K.H., John M., and White P.C. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc. Natl. Acad. Sci. U.S.A. 84 20 (1987) 7193-7197
9. Cicila G., Rapp J.R., Wang J.-M., St Lezin E., Ng S., and Kurtz T.W. Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in Dahl rat. Nat. Genet. 3 (1993) 346-353
10. Cicila G.T., Garrett M.R., Lee S.J., Liu J., Dene H., and Rapp J.R. High-resolution mapping of the blood pressure QTL on chromosome 7 using Dahl rat congenic strains. Genomics 72 1 (2001) 51-60
11. Coll A.P., Challis B.G., Yeo G.S., Snell K., Piper S.J., Halsall D., Thresher R.R., and O'Rahilly S. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145 10 (2004) 4721-4727
12. Connell J.M.C., Whitworth J., Davies D., Lever A., Richards A., and Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J. Hypertens. 5 (1987) 425-433
13. Cover C.M., Wang J.M., St Lezin E., Kurtz T., and Mellon S.H. Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J. Biol. Chem. 270 (1995) 16555-16560
14. Daidoh H., Morita H., Mune T., Murayama M., Hanafusa J., Ni H., Shibata H., and Yasuda K. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clin. Endocrinol. (Oxf) 43 3 (1995) 311-315
15. Davies E., Holloway C.D., Ingram M.C., Friel E.C., Inglis G.C., Swan L., Hillis W.S., Fraser R., and Connell J.M.C. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin. Endocrinol. 54 (2001) 813-817
16. Davies E., Holloway C.D., Ingram M.C., Inglis G.C., Friel E.C., Morrison C., Anderson N.H., Fraser R., and Connell J.M.C. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33 (1999) 703-707
17. Davies E., and MacKenzie S.M. Extra-adrenal production of corticosteroids. Clin. Exp. Pharmacol. Physiol. 30 (2003) 437-445
18. de Simone G., Tommaselli A., Rossi R., Valentino R., Lauria R., Scopacasa F., and Lombardi G. Partial deficiency of adrenal 11β-hydroxylase-a possible cause of primary hypertension. Hypertension 7 (1985) 613-618
19. Fardella C.E., Hum D.W., Rodriguez H., Zhang G., Barry F.L., Ilicki A., Bloch C.A., and Miller W.L. Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency. J. Clin. Endocrinol. Metab. 81 1 (1996) 321-326
20. Fardella C.E., Rodriguez H., Montero J., Zhang G., Vignolo P., Rojas A., Villarroel L., and Miller W.L. Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J. Clin. Endocrinol. Metab. 81 (1996) 4347-4351
21. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner N.W., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., and McCarthy M.I. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 5826 (2007) 889-894
22. Freel E.M., Ingram M., Friel E.C., Fraser R., Brown M., Samani N.J., Caulfield M., Munroe P., Farrall M., Webster J., Clayton D., Dominiczak A.F., Davies E., and Connell J.M. Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study. Clin. Endocrinol. (Oxf) 67 6 (2007) 832-838
23. Freel E.M., Ingram M., Wallace A.M., White A., Fraser R., Davies E., and Connell J.M. Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects. Clin. Endocrinol. (Oxf) 68 5 (2008) 700-706
24. Fuchs-Hammoser R., Schweiger M., and Oelkers W. The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man. Acta Endocrinol. (Copenh) 95 2 (1980) 198-206
25. Funder J.W., Pearce P.T., Smith R., and Smith I.A. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585
26. Ganapathipillai S., Laval G., Hoffmann I.S., Castejon A.M., Nicod J., Dick B., Frey F.J., Frey B.M., Cubeddu L.X., and Ferrari P. CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J. Clin. Endocrinol. Metab. 90 2 (2005) 1220-1225
27. Goodfriend T.L., Egan B.M., and Kelley D.E. Aldosterone in obesity. Endocr. Res. 24 3-4 (1998) 789-796
28. Griffing G.T., Berelowitz B., Hudson M., Salzman R., Manson J.A., Aurrechia S., Melby J.C., Pedersen R.C., and Brownie A.C. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension. J. Clin. Invest. 76 1 (1985) 163-169
29. Hautanena A., Lankinen L., Kupari M., Janne O.A., Adlercreutz H., Nikkila H., and White P.C. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J. Intern. Med. 244 1 (1998) 11-18
30. Imrie H., Freel M., Mayosi B.M., Davies E., Fraser R., Ingram M., Cordell H.J., Farrall M., Avery P.J., Watkins H., Keavney B., and Connell J.M. Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. J. Clin. Endocrinol. Metab. 91 12 (2006) 5051-5056
31. Inglis G.C., Ingram M.C., Holloway C.D., Swan L., Birnie D., Hillis W.S., Davies E., Fraser R., and Connell J.M.C. Familial pattern of corticosteroids and their metabolism in adult human subjects-the Scottish adult twin study. J. Clin. Endocrinol. Metab. 84 (1999) 4132-4137
32. James V.H., Tunbridge R.D., and Wilson G.A. Studies on the control of aldosterone secretion in man. J. Steroid Biochem. 7 11-12 (1976) 941-948
33. Kathiresan S., Larson M.G., Benjamin E.J., Corey D., Murabito J.M., Fox C.S., Wilson P.W., Rifai N., Meigs J.B., Ricken G., Lifton R.P., Levy D., and Vasan R.S. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am. J. Hypertens. 18 5 Pt 1 (2005) 657-665
34. Katz F.H., Romfh P., and Smith J.A. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J. Clin. Endocrinol. Metab. 40 1 (1975) 125-134
35. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
36. Keavney B., Mayosi B., Gaukrodger N., Imrie H., Baker M., Fraser R., Ingram M., Watkins H., Farrall M., Davies E., and Connell J. Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J. Clin. Endocrinol. Metab. 90 2 (2005) 1072-1077
37. Kem D.C., Gomez-Sanchez C., Kramer N.J., Holland O.B., and Higgins J.R. Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man. J. Clin. Endocrinol. Metab. 40 1 (1975) 116-124
38. Komiya I., Yamada T., Takara M., Asawa T., Shimabukuro M., Nishimori T., and Takasu N. Lys173Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35 (2000) 699-703
39. Kotchen T.A., Kotchen J.M., Grim C.E., George V., Kaldunski M.L., Cowley A.W., Hamet P., and Chelius T.H. Genetic determinants of hypertension: identification of candidate phenotypes. Hypertension 36 1 (2000) 7-13
40. Lim P.O., MacDonald T.M., Holloway C.D., Friel E.C., Anderson N.H., Dow E., Jung R.T., Davies E., Fraser R., and Connell J.M.C. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio. J. Clin. Endocrinol. Metab. 87 (2002) 4398-4402
41. Lin L., Hindmarsh P.C., Metherell L.A., Alzyoud M., Al Ali M., Brain C.E., Clark A.J., Dattani M.T., and Achermann J.C. Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clin. Endocrinol. (Oxf) 66 2 (2007) 205-210
42. Luft F.C., Rankin L.I., Bloch R., Weyman A.E., Willis L.R., Murray R.H., Grim C.E., and Weinberger M.H. Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 60 3 (1979) 697-706
43. Matsukawa N., Nonaka N., Higaki J., Nagano M., Mikami H., Ogihara T., and Okamoto M. DahI's salt-resistant normotensive rat has mutations in cytochrome P450(11β), but the salt-sensitive hypertensive rat does not. J. Biol. Chem. 268 (1993) 9117-9121
44. McDougall J.G., Butkus A., Coghlan J.P., Denton D.A., Muller J., Oddie C.J., Robinson P.M., and Scoggins B.A. Biosynthetic ad morphological evidence for inhibition of aldosterone production following administration of ACTH to sheep. Acta Endocrinol. (Copenh) 94 4 (1980) 559-570
45. Mornet E., Dupont J., Vitek A., and White P.C. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J. Biol. Chem. 264 35 (1989) 20961-20967
46. Mulatero P., Stowasser M., Loh K.C., Fardella C.E., Gordon R.D., Mosso L., Gomez-Sanchez C.E., Veglio F., and Young Jr. W.F. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89 3 (2004) 1045-1050
47. Newton-Cheh C., Guo C.Y., Gona P., Larson M.G., Benjamin E.J., Wang T.J., Kathiresan S., O'Donnell C.J., Musone S.L., Camargo A.L., Drake J.A., Levy D., Hirschhorn J.N., and Vasan R.S. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49 4 (2007) 846-856
48. Nonaka Y., Fujii T., Kagawa N., Waterman M.R., Takemori H., and Okamoto M. Structure/function relationship of CYP11B1 associated with Dahl's salt-resistant rats-expression of rat CYP11B1 and CYP11B2 in Escherichia coli. Eur. J. Biochem. 258 2 (1998) 869-878
49. Oelkers W. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. Acta Endocrinol. 108 1 (1985) 91-97
50. Oelkers W., Brown J.J., Fraser R., Lever A.F., Morton J.J., and Robertson J.I.S. Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ. Res. (1974) 69-77
51. Olivieri O., Ciacciarelli A., Signorelli D., Pizzolo F., Guarini P., Pavan C., Corgnati A., Falcone S., Corrocher R., Micchi A., Cressoni C., and Blengio G. Aldosterone to Renin ratio in a primary care setting: the Bussolengo study. J. Clin. Endocrinol. Metab. 89 9 (2004) 4221-4226
52. Paillard F., Chansel D., Brand E., Benetos A., Thomas F., Czekalski S., Ardaillou R., and Soubrier F. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34 (1999) 423-429
53. Phillips D.I.W., Walker B.R., Reynolds R.M., Flanagan D.E.H., Wood P.J., Osmond C., Barker D.J.P., and Whorwood C.B. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35 (2000) 1301-1306
54. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Rittman R., Hurley S., Kleiman J., and Gatlin M. Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348 14 (2003) 1309-1321
55. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341 10 (1999) 709-716
56. Pojoga L., Gautier S., Blanc H., Guyene T.T., Poirier O., Cambien F., and Benetos. Genetic determination of plasma aldosterone levels in essential hypertension. Am. J. Hypertens. 11 7 (1998) 856-860
57. Pratt J.H., Dale S.L., and Melby J.C. The effect of administered ACTH on aldosterone metabolism and secretion. J. Clin. Endocrinol. Metab. 42 2 (1976) 355-360
58. Rapp J.P., and Dahl L.K. Possible role of 18-hydroxy-deoxycorticosterone in hypertension. Nature 237 5354 (1972) 338-339
59. Reynolds R., Walker B., Phillips D., Sydall H., Davies E., Fraser R., and Connell J.M. Acute aldosterone responses to ACTH predict both cortisol responses and blood pressure. Endocr. Abstracts 13 (2007) OC24
60. Richards A.M., Nicholls M.G., Espiner E.A., Ikram H., Cullens M., and Hinton D. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin. Exp. Hypertens. A 8 2 (1986) 153-166
61. Rossi G.P., Bernini G., Caliumi C., Desideri G., Fabris B., Ferri C., Ganzaroli C., Giacchetti G., Letizia C., Maccario M., Mallamaci F., Mannelli M., Mattarello M.J., Moretti A., Palumbo G., Parenti G., Porteri E., Semplicini A., Rizzoni D., Rossi E., Boscaro M., Pessina A.C., and Mantero F. A prospective study of the prevalence of primary aldosteronism in 1.125 hypertensive patients. J. Am. Coll. Cardiol. 48 11 (2006) 2293-2300
62. Schambelan M., Brust N.L., Chang B.C., Slater K.L., and Biglieri E.G. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J. Clin. Endocrinol. Metab. 43 1 (1976) 115-131
63. Sookoian S., Gianotti T.F., Gonzalez C.D., and Pirola C.J. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J. Hypertens. 25 1 (2007) 5-13
64. Soro A., Ingram M.C., Tonolo G., Glorioso N., and Fraser R. Mildly raised corticosterone excretion rates in patients with essential hypertension. J. Hum. Hypertens. 9 6 (1995) 391-393
65. Stewart P.M., Corrie J.E., Shackleton C.H., and Edwards C.R. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82 1 (1988) 340-349
66. Stockand J.D. New ideas about aldosterone signaling in epithelia. Am. J. Physiol. Renal Physiol. 282 4 (2002) F559-F576
67. Tanahashi H., Mune T., Takahashi Y., Isaji M., Suwa T., Morita H., Yamakita N., Yasuda K., Deguchi T., White P.C., and Takeda J. Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 90 11 (2005) 6226-6231
68. Tsujita Y., Iwai N., Katsuya T., Higaki J., Ogihara T., Tamaki S., Kinoshita M., Mannami T., Ogata J., and Baba S. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study. Hypertens. Res. 24 (2001) 105-109
69. Tsunoda K., Abe K., Goto T., Yasujima M., Sato M., Omata K., Seino M., and Yoshinaga K. Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma. J. Clin. Endocrinol. Metab. 62 2 (1986) 384-389
70. Tucci J.R., Espiner E.A., Jagger P.I., Pauk G.L., and Lauler D.P. ACTH stimulation of aldosterone secretion in normal subjects and in patients with chronic adrenocortical insufficiency. J. Clin. Endocrinol. Metab. 27 4 (1967) 568-575
71. Vasan R.S., Evans J.C., Larson M.G., Wilson P.W., Meigs J.B., Rifai N., Benjamin E.J., and Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N. Engl. J. Med. 351 1 (2004) 33-41
72. Wagner M., Ge Y., and Siciliano Wells D. A hybrid cell mapping panel for regional localisation of probes to human chromosome 8. Genomics 10 (1991) 114-125
73. Weidmann P., Beretta-Piccoli C., Ziegler W.H., Keusch G., Gluck Z., and Reubi F.C. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int. 14 6 (1978) 619-628
74. White P.C., and Slutsker L. Haplotype analysis of CYP11B2. Endocr. Res. 21 1-2 (1995) 437-442
75. Young W.F. Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol. (Oxf) 66 5 (2007) 607-618